Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.01
Delayed Data
As of 3:59pm ET
 -0.01 / -0.25%
Today’s Change
2.63
Today|||52-Week Range
6.30
+10.77%
Year-to-Date
Minerva Presents Additional Data from Schizophrenia Drug
10:51am / Zacks.com - Paid Partner Content
Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter
Jan 19 / Zacks.com - Paid Partner Content
Aduro (ADRO) Inks License Agreement with Stanford University
Jan 20 / Zacks.com - Paid Partner Content
Kura Oncology Starts Dosing Patients in Phase II CMML Study
Jan 18 / Zacks.com - Paid Partner Content
Synergy (SGYP) Trulance Wins FDA Approval for Constipation
Jan 20 / Zacks.com - Paid Partner Content